DEADLINE: 28TH DECEMBER, 2023
JHPIEGO CORPORATION
EXPRESSION OF INTEREST FROM WORLD HEALTH ORGANIZATION (WHO) FOR PRE-QUALIFIED PHARMACEUTICAL COMPANIES IN NIGERIA

Jhpiego is an international, an affiliated with Johns Hopkins University, is an international non-profit, non-governmental organization that works to improve the health of women and families throughout the world.

Jhpiego Corporation is seeking to procure Pharmaceutical drugs from WHO Pre-qualified Pharmaceutical companies for Hepatitis, Malaria and other diseases.

Qualified Pharmaceutical companies and Drugs Manufacturers are encouraged to read the entire document to ensure that they have a clear understanding of Jhpiego requirements before submitting expression of interest.

Successful companies would be in the approved Jhpiego’s vendor’s database on multi-year basis and would become the first point of contact regarding purchase of Pharmaceutical drugs.

ELIGIBILITY
All expression of interest should be accompanied with the following:

  • Cope of WHO certification that supports pre-qualification.
  • Copy of certificate of registration/incorporation, including memorandum and articles of association, constitution, valid corporate Tax Identification Number (TIN) and any other related document.
  • Organizational profile (briefly reflecting the core competencies, key management personnel and clearly stating the physical verifiable office address, mobile number and e-mail address.
  • Any other proof or licence as given by the appropriate regulatory body (if applicable) to authorize business operations.
  • Minimum of three (3) reputable references within the last three years from Clients/Organizations where similar supply was successfully rendered.

MODE OF SUBMISSION

Submissions should be sent via email to: Nigeria.Bids@jhpiego.org within the timeline stated below, with subject “EOI: WHO Pre-qualified Pharmaceutical Companies in Nigeria”.

CLOSING DATE
The closing date for the submission of Expression of interest is at 4pm WAT on 28th December, 2023.